Sancho, J., Marin-Niebla, A., Fernandez, S., Capote, F., Canigral, C., Grande, C., . . . Rubio-Azpeitia, E. (2022). IBRORS-MCL study: A Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
Citación estilo ChicagoSancho, Juan-Manuel, et al. IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/refractory Mantle-cell Lymphoma Treated With Ibrutinib in Routine Clinical Practice. 2022.
Cita MLASancho, Juan-Manuel, et al. IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/refractory Mantle-cell Lymphoma Treated With Ibrutinib in Routine Clinical Practice. 2022.
Precaución: Estas citas no son 100% exactas.